Pyrazolo(l,5-a) (1, 3, 5) triazine and pyrazolo (1, 5-a) pyrimidine derivatives useful as protein kinase inhibitors

Details for Australian Patent Application No. 2007297675 (hide)

Owner Polaris Group

Inventors Erickson, Philip Eugene; Nie, Zhe; Perretta, Carin L.; Chu, Shaosong

Agent Watermark

Pub. Number AU-B-2007297675

PCT Pub. Number WO2008/036277

Priority 60/845,314 18.09.06 US; 11/856,476 17.09.07 US

Filing date 18 September 2007

Wipo publication date 27 March 2008

Acceptance publication date 20 September 2012

International Classifications

C07D 487/16 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61K 31/53 - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 35/00 Antineoplastic agents

A61P 37/00 Drugs for immunological or allergic disorders

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/036277 Priority application(s): WO2008/036277

20 September 2012 Application Accepted

  Published as AU-B-2007297675

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007297676-Switching multiple link layer resources for media independent handover

2007297674-Balancing heat of solution in non-free flowing sweetener compositions